Fig. 6
From: CD133 significance in glioblastoma development: in silico and in vitro study
The scratch assay and the mRNA expression of MMP16. A The scratch assay for assessing the migration of U87MG cells in different studied groups. The combined CD133 silencing with temozolomide decreases the migration of U87MG cells compared to temozolomide monotherapy. B The mRNA expression of MMP16 in different studied groups. CD133 silencing downregulates the expression of MMP16 in U87MG cells. ****P-value ≤ 0.0001